UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update

Journal of clinical oncology, 2020-10, Vol.38 (28), p.3325-3348

2020

Volltextzugriff (PDF)

Scleroderma‐like skin changes induced by checkpoint inhibitor therapy

Journal of cutaneous pathology, 2018-08, Vol.45 (8), p.615-618

2018

Volltextzugriff (PDF)

Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia

Haematologica (Roma), 2022-10, Vol.107 (10), p.2523-2526

2022

Volltextzugriff (PDF)

Malignant＂ Perivascular Epithelioid Cell Neoplasm: Risk Stratification and Treatment Strategies

Complexity (New York, N.Y.), 2012, Vol.2012 (2012), p.1-12

2012

Volltextzugriff (PDF)

Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma

Clinical cancer research, 2015-09, Vol.21 (18), p.4224-4233

2015

Volltextzugriff (PDF)

Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab

Hematology, Transfusion and Cell Therapy, 2021-07, Vol.43 (3), p.364-367

2021

Volltextzugriff (PDF)

Distinct Clinical Characteristics in Young-Onset Pancreatic Neuroendocrine Tumor

Cancers, 2020-09, Vol.12 (9), p.2501

2020

Volltextzugriff (PDF)

Response to Alemtuzumab in FIP1L1/PDGFRA-Negative Hypereosinophilic Myocarditis on Serial Cardiac Magnetic Resonance Imaging

Journal of the American College of Cardiology, 2012-01, Vol.59 (4), p.430-430

2012

Volltextzugriff (PDF)

Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology program

Surgery open science, 2020-10, Vol.2 (4), p.25-31

2020

Volltextzugriff (PDF)

EBV-Associated Lymphoproliferative Disorder and Hemophagocytic Lymphohistiocytosis in a Patient with Severe Celiac Disease

Case reports in hematology, 2018-01, Vol.2018 (2018), p.1-4

2018

Volltextzugriff (PDF)

Treatment-refractory idiopathic hypereosinophilic syndrome: Pitfalls and progress with use of novel drugs

American journal of hematology, 2012-07, Vol.87 (7), p.703-706

2012

Volltextzugriff (PDF)

Extranodal Rosai-Dorfman Disease Presenting as a Pericardial Mass and Constrictive Pericarditis

JACC. Case reports, 2019-12, Vol.1 (4), p.643-647

2019

Volltextzugriff (PDF)

Malignant perivascular epithelioid cell tumor of the uterus

Rare tumors, 2012-01, Vol.4 (1), p.e14-48

2012

Volltextzugriff (PDF)

Oncology patient and provider preferences regarding rapid radiology result release to online portals

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1544-1544

2021

Volltextzugriff (PDF)

Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study

JCO precision oncology, 2018-11 (2), p.1-12

2018

Volltextzugriff (PDF)

Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation

European journal of haematology, 2012-09, Vol.89 (3), p.228-235

2012

Volltextzugriff (PDF)

Clinical outcomes of checkpoint inhibitors in metastatic non-clear cell renal cell carcinoma and clear cell renal cell carcinoma with variant features

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e17065-e17065

2020

Volltextzugriff (PDF)

Survival analysis of CLL/SLL patients with Richter’s transformation to DLBCL: An analysis of the SEER database

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e20024-e20024

2020

Volltextzugriff (PDF)

Complete and Prolonged Response of Renal Cell Carcinoma With Rhabdoid Features to Checkpoint Inhibitor Therapy

Journal of immunotherapy (1997), 2018-09, Vol.41 (7), p.340-342

2018

Volltextzugriff (PDF)

Prognostic implications of tumor sidedness in colorectal cancer patients in South Dakota, 2006-2015

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.46-46

2020

Volltextzugriff (PDF)

COVID-19 infection in patients on anti-CD20 monoclonal antibodies: Changes in clinical outcomes and management over time

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e19542-e19542

2023

Volltextzugriff (PDF)

Effectiveness of immunotherapy versus BRAF/MEK inhibitors in treatment-naïve BRAF-mutant advanced melanoma: A single institution retrospective analysis

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21515-e21515

2022

Volltextzugriff (PDF)

Alliance A022102: Randomized phase III trial of mFOLFIRINOX +/- nivolumab vs. FOLFOX +/- nivolumab for first-line treatment of metastatic HER2-negative gastroesophageal adenocarcinoma (GEA)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS4175-TPS4175

2023

Volltextzugriff (PDF)

Expanding rural access to phase I clinical trials

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18525-e18525

2023

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(48)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(23)
Humans
(12)
Oncology
(10)
Female
(8)
Case Report
(5)
Hematology
(5)
Male
(5)
Middle Aged
(5)
Antibodies, Monoclonal, Humanized - Therapeutic Use
(4)
Patients
(4)
Adult
(3)
Gastroenterology & Hepatology
(3)
Surgery
(3)
Treatment Outcome
(3)
Adipose Tissue
(2)
Aged
(2)
Animals
(2)
Antibodies, Monoclonal, Humanized - Adverse Effects
(2)
Antineoplastic Agents - Adverse Effects
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update

Scleroderma‐like skin changes induced by checkpoint inhibitor therapy

Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia

Malignant＂ Perivascular Epithelioid Cell Neoplasm: Risk Stratification and Treatment Strategies

Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma

Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab

Distinct Clinical Characteristics in Young-Onset Pancreatic Neuroendocrine Tumor

Response to Alemtuzumab in FIP1L1/PDGFRA-Negative Hypereosinophilic Myocarditis on Serial Cardiac Magnetic Resonance Imaging

Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology program

EBV-Associated Lymphoproliferative Disorder and Hemophagocytic Lymphohistiocytosis in a Patient with Severe Celiac Disease

Treatment-refractory idiopathic hypereosinophilic syndrome: Pitfalls and progress with use of novel drugs

Extranodal Rosai-Dorfman Disease Presenting as a Pericardial Mass and Constrictive Pericarditis

Malignant perivascular epithelioid cell tumor of the uterus

Oncology patient and provider preferences regarding rapid radiology result release to online portals

Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study

Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation

Clinical outcomes of checkpoint inhibitors in metastatic non-clear cell renal cell carcinoma and clear cell renal cell carcinoma with variant features

Survival analysis of CLL/SLL patients with Richter’s transformation to DLBCL: An analysis of the SEER database

Complete and Prolonged Response of Renal Cell Carcinoma With Rhabdoid Features to Checkpoint Inhibitor Therapy

Prognostic implications of tumor sidedness in colorectal cancer patients in South Dakota, 2006-2015

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial

COVID-19 infection in patients on anti-CD20 monoclonal antibodies: Changes in clinical outcomes and management over time

Effectiveness of immunotherapy versus BRAF/MEK inhibitors in treatment-naïve BRAF-mutant advanced melanoma: A single institution retrospective analysis

Alliance A022102: Randomized phase III trial of mFOLFIRINOX +/- nivolumab vs. FOLFOX +/- nivolumab for first-line treatment of metastatic HER2-negative gastroesophageal adenocarcinoma (GEA)

Expanding rural access to phase I clinical trials

Aktive Filter

Suchergebnisse filtern